Advanced early detection test for lung cancer screening utilizing molecular diagnostic technology. This in-development product represents the company's expansion into early detection for pulmonary malignancies. The test is designed for high-risk population screening and clinical intervention.
Manufactured by
China
BioChain (Beijing) Science & Technology Inc. is a pioneer in cancer early diagnosis and screening in China. The company specializes in developing NGS and PCR-based cancer gene methylation detection products, focusing on early cancer diagnosis reagent kits and large-scale laboratory screening platforms.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Singlera GENOMICS (SHANGHAI) Ltd.
China · 7 relevant products
Acon Biotech (Hangzhou) Co., Ltd.
China · 1 relevant product
Ease Healthcare
United States · 2 relevant products
guangzhou biotron technolongy co.,ltd
China · 1 relevant product
Biomerica, Inc.
United States · 1 relevant product
STRATEC/Diatron
Germany · 1 relevant product
Jiangsu Sunlant Bioengineering Co., Ltd.
China · 1 relevant product
HLB PANAGENE Co., Ltd.
South Korea · 2 relevant products
ACON Laboratories, Inc.
United States · 1 relevant product
GMA Group Trading
Egypt · 1 relevant product
51 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →11 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 87 closest product alternatives
Singlera GENOMICS (SHANGHAI) Ltd. · China
A molecular diagnostic test utilizing DNA methylation technology for early detection of lung cancer. Enables risk assessment and early diagnosis of lung malignancies through liquid biopsy methodology.
Acon Biotech (Hangzhou) Co., Ltd. · China
Molecular diagnostic test for cancer detection and tumor marker analysis. Supports early detection of various cancer types.
Singlera GENOMICS (SHANGHAI) Ltd. · China
A DNA methylation-based molecular diagnostic test designed for early detection and risk assessment across multiple cancer types. The test utilizes proprietary methylation technology to identify cancer signals in biological samples.
Singlera GENOMICS (SHANGHAI) Ltd. · China
A DNA methylation-based diagnostic solution for early detection of esophageal cancer. Enables risk assessment and molecular diagnosis of esophageal malignancies.
Singlera GENOMICS (SHANGHAI) Ltd. · China
A specialized molecular diagnostic test for early detection and risk assessment of pancreatic cancer using DNA methylation technology. Supports early diagnosis of this highly aggressive malignancy.
Ease Healthcare · United States
Blood test for assessing lung cancer risk in vulnerable populations, including those with age or smoking history risk factors, enabling early detection and intervention.
guangzhou biotron technolongy co.,ltd · China
Molecular diagnostic assay utilizing circulating tumor cell and cell-free DNA analysis to support pulmonary nodule characterization and malignancy risk assessment.
Biomerica, Inc. · United States
An advanced diagnostic test for prostate cancer screening. Designed as an at-home screening product targeting high-prevalence cancer detection.
Singlera GENOMICS (SHANGHAI) Ltd. · China
A molecular diagnostic test based on DNA methylation for early detection and diagnosis of gastric cancer. Supports risk stratification and early screening for gastric malignancies.
Ease Healthcare · United States
LEAP is a simple blood test that helps doctors assess lung cancer risk in people who may be more vulnerable due to factors like age or smoking history, even if they have no symptoms.
STRATEC/Diatron · Germany
In-vitro diagnostic test for detecting tumor markers and cancer-related antigens in blood and other biological samples. The test aids in cancer screening, diagnosis, and treatment monitoring.
Singlera GENOMICS (SHANGHAI) Ltd. · China
A DNA methylation-based diagnostic test for early detection and risk assessment of hepatocellular carcinoma. Provides comprehensive screening capabilities for liver cancer malignancies.
75 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products